Research analysts at StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a report issued on Sunday. The firm set a “sell” rating on the medical device company’s stock. Separately, HC Wainwright restated a “buy” rating and set a $1.60 price target on shares of Avinger in a report on Friday, […]